Results 221 to 230 of about 14,856,428 (286)

A two-phase low-dose ACD-A strategy overcomes hypocalcemia during peripheral blood stem cell collection: a randomized controlled study. [PDF]

Front Oncol
Long Z, Jin Y, Zhao D, Li Y, Hou Z, Ruan M, Hong J, Dai J, Liang X, Li Q, Ge J.   +10 more
europepmc   +1 more source

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

British Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu, Kaibin Dai, Zhensheng Lin, Mingfang Ye, Minfeng Chen, Xiaobo Li, Dongmei Zhang   +6 more
wiley   +1 more source

Primary breast diffuse large B-cell lymphoma mimicking breast carcinoma: a case report. [PDF]

Front Oncol
Jiang R, Chen D, Wu L, Zhao L, Hu G.
europepmc   +1 more source

Cancer pain: current practice and emerging targets

British Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye, Marcin Chwistek, Zhiting Gong, Vanessa Uzonwanne, Xiaojie Shi, Arpad Szallasi   +5 more
wiley   +1 more source

Drug reaction with eosinophilia and systemic symptoms or peripheral T-cell lymphoma? That is the question. [PDF]

Postepy Dermatol Alergol
Grabarczyk M, Swoboda R, Michalak K, Ponikiewska D, Smyk J, Krawczyk-Kuliś M, Giebel S, Pastuszczak M, Kamińska-Winciorek G.   +8 more
europepmc   +1 more source

A comprehensive review of cancer‐induced cardiac wasting

British Journal of Pharmacology, EarlyView.
Cancer is frequently accompanied by cachexia, a systemic syndrome characterized by progressive loss of skeletal muscle mass, with or without loss of fat mass. Increasing evidence indicates that cancer can also induce cardiac muscle wasting, which is associated with structural cardiac remodelling, impaired contractile function and the development of ...
Alessia Lena, Muhammad Shahzeb Khan, Ulrich Keller, Lars Bullinger, Dominik P. Modest, Markus S. Anker   +5 more
wiley   +1 more source

Updated Real-World Outcomes with Brentuximab Vedotin in Chinese Lymphoma Patients: A Multicenter, Retrospective Study. [PDF]

Drug Des Devel Ther
Qiao H, Liu X, Nan H, Zhang M, Bai Y, Zhou K, Zhang X.   +6 more
europepmc   +1 more source

CD93—An emerging vascular target in cancer therapy

British Journal of Pharmacology, EarlyView.
Abstract CD93 is a single‐pass transmembrane glycoprotein that belongs to the C‐type lectin domain group XIV family of proteins. Although it is known to be expressed in other cell types, namely, in some subsets of immune cells, CD93 is primarily expressed on endothelial cells, where it acts as a crucial regulator of angiogenesis.
Beatriz de Alves Pereira, Stefano Barbera, Roberta Lugano, Anna Dimberg   +3 more
wiley   +1 more source

A Six-year Response to Belinostat in a Highly Probable Case of Relapsed/Refractory MF/SS Initially Classified as PTCL-NOS: A Case Report. [PDF]

Onco Targets Ther
Gauthier N, Reimbold P, Bravetti C, Sepporta MV, Le Garff-Tavernier M, Choquet S, Maloum K.   +6 more
europepmc   +1 more source

Unmasking a Composite Lymphoma: Follicular Lymphoma Emerging After Bispecific Antibody Treatment of Marginal Zone Lymphoma. [PDF]

EJHaem
Orosco-Ttamina AL, Zhou J, Biondo J, Hossain F, Viswanatha D, Greipp PT, Lewis N, Munoz J.   +7 more
europepmc   +1 more source